Linezolid Alone and in Combination with Rifampicin Prevents Experimental Vascular Graft Infection Due to Methicillin-Resistant Staphylococcus aureus and Staphylococcus epidermidis

2007 ◽  
Vol 139 (2) ◽  
pp. 170-175 ◽  
Author(s):  
Mustafa Sacar ◽  
Suzan Sacar ◽  
Ilknur Kaleli ◽  
Gokhan Onem ◽  
Huseyin Turgut ◽  
...  
Infection ◽  
2019 ◽  
Vol 48 (2) ◽  
pp. 309-310 ◽  
Author(s):  
Arturo Ciccullo ◽  
Gabriele Giuliano ◽  
Francesco Vladimiro Segala ◽  
Eleonora Taddei ◽  
Damiano Farinacci ◽  
...  

2004 ◽  
Vol 48 (8) ◽  
pp. 3162-3164 ◽  
Author(s):  
Andrea Giacometti ◽  
Oscar Cirioni ◽  
Roberto Ghiselli ◽  
Fiorenza Orlando ◽  
Giuseppina D'Amato ◽  
...  

ABSTRACT The efficacy of linezolid and temporin A in the prevention of prosthetic graft infection due to methicillin-resistant Staphylococcus epidermidis with intermediate resistance to glycopeptides was investigated in a subcutaneous rat pouch model. Linezolid and temporin A, alone or combined, greatly reduced the bacterial numbers compared to the effect with control drugs.


mBio ◽  
2021 ◽  
Author(s):  
Liang Li ◽  
Yi Li ◽  
Fengli Zhu ◽  
Ambrose L. Cheung ◽  
Genzhu Wang ◽  
...  

Persistent endovascular infections caused by MRSA, including vascular graft infection syndromes and infective endocarditis, are significant and growing public health threats. A particularly worrisome trend is that most MRSA isolates from these patients are “susceptible” in vitro to conventional anti-MRSA antibiotics, such as VAN and daptomycin (DAP), based on Clinical and Laboratory Standards Institute breakpoints.


2012 ◽  
Vol 64 (4) ◽  
pp. 441-444 ◽  
Author(s):  
Laurence Legout ◽  
Piervito D’Elia ◽  
Patrick Devos ◽  
Nicolas Ettahar ◽  
Beatrice Sarraz-Bournet ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document